| Indicator | Meropenem (n=7) | Vancomycin (n=5) | Ceftriaxone (n=7) | P value |
|---|
| Age/year | 69 (60, 77) | 71 (58, 80) | 64 (58, 71) | 0.198 | | Male/n(%) | 6 (85.7) | 5 (100.0) | 7 (100.0) | 0.059 | | DWa/kg | 66.0 (48.0, 73.5) | 58.1 (48.0, 65.0) | 63.0 (55.7, 75.0) | 0.167 | | BMI/(kg·m-2) | 24.1 (18.8, 27.5) | 21.8 (19.2, 25.2) | 22.4 (20.5, 25.4) | 0.274 | | eGFRb/[mL·(min·1.73 m2)-1] | 10.1 (4.0, 28.0) | 7.4 (4.0, 12.0) | 9.1 (5.0, 13.0) | 0.545 | | ALT/(U·L-1) | 13.6 (6.0, 34.0) | 22.8 (7.0, 37.0) | 15.4 (3.0, 30.0) | 0.492 | | AST/(U·L-1) | 15.6 (8.0, 32.0) | 21.8 (12.0, 36.0) | 20.7 (6.0, 28.0) | 0.273 | | TP/(g·L-1) | 61.9 (49.0, 72.0) | 67.4 (62.0, 77.0) | 61.6 (49.0, 79.0) | 0.325 | | Alb /(g·L-1) | 31.6 (20.0, 38.0) | 34.6 (29.0, 40.0) | 35.0 (23.0, 42.0) | 0.539 | | HCT | 0.278 (0.191, 0.383) | 0.288 (0.214, 0.355) | 0.276 (0.198, 0.332) | 0.866 | | Qb/(mL·min-1) | 212.9 (200.0, 240.0) | 218.0 (200.0, 230.0) | 217.1 (200.0, 250.0) | 0.893 | | UF/L | 2.6 (2.0‒3.5) | 2.2 (1.6‒3.3) | 2.6 (1.3‒3.3) | 0.485 |
|